Covid-19 Impact on Global Heparin Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global Heparin Market Size, Status and Forecast 2020-2026

Table of Contents
1 Study Coverage
1.1 Heparin Product Introduction
1.2 Market Segments
1.3 Key Heparin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Heparin Market Size Growth Rate by Type
1.4.2 Heparin Sodium
1.4.3 Heparin Calcium
1.4.4 Other
1.5 Market by Application
1.5.1 Global Heparin Market Size Growth Rate by Application
1.5.2 UFH
1.5.3 LMWH
1.6 Coronavirus Disease 2019 (Covid-19): Heparin Industry Impact
1.6.1 How the Covid-19 is Affecting the Heparin Industry
1.6.1.1 Heparin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Heparin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Heparin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Heparin Market Size Estimates and Forecasts
2.1.1 Global Heparin Revenue 2015-2026
2.1.2 Global Heparin Sales 2015-2026
2.2 Heparin Market Size by Region: 2020 Versus 2026
2.2.1 Global Heparin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Heparin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Heparin Competitor Landscape by Players
3.1 Heparin Sales by Manufacturers
3.1.1 Heparin Sales by Manufacturers (2015-2020)
3.1.2 Heparin Sales Market Share by Manufacturers (2015-2020)
3.2 Heparin Revenue by Manufacturers
3.2.1 Heparin Revenue by Manufacturers (2015-2020)
3.2.2 Heparin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Heparin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Heparin Revenue in 2019
3.2.5 Global Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Heparin Price by Manufacturers
3.4 Heparin Manufacturing Base Distribution, Product Types
3.4.1 Heparin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Heparin Product Type
3.4.3 Date of International Manufacturers Enter into Heparin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Heparin Market Size by Type (2015-2020)
4.1.1 Global Heparin Sales by Type (2015-2020)
4.1.2 Global Heparin Revenue by Type (2015-2020)
4.1.3 Heparin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Heparin Market Size Forecast by Type (2021-2026)
4.2.1 Global Heparin Sales Forecast by Type (2021-2026)
4.2.2 Global Heparin Revenue Forecast by Type (2021-2026)
4.2.3 Heparin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Heparin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Heparin Market Size by Application (2015-2020)
5.1.1 Global Heparin Sales by Application (2015-2020)
5.1.2 Global Heparin Revenue by Application (2015-2020)
5.1.3 Heparin Price by Application (2015-2020)
5.2 Heparin Market Size Forecast by Application (2021-2026)
5.2.1 Global Heparin Sales Forecast by Application (2021-2026)
5.2.2 Global Heparin Revenue Forecast by Application (2021-2026)
5.2.3 Global Heparin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Heparin by Country
6.1.1 North America Heparin Sales by Country
6.1.2 North America Heparin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Heparin Market Facts & Figures by Type
6.3 North America Heparin Market Facts & Figures by Application
7 Europe
7.1 Europe Heparin by Country
7.1.1 Europe Heparin Sales by Country
7.1.2 Europe Heparin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Heparin Market Facts & Figures by Type
7.3 Europe Heparin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Heparin by Region
8.1.1 Asia Pacific Heparin Sales by Region
8.1.2 Asia Pacific Heparin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Heparin Market Facts & Figures by Type
8.3 Asia Pacific Heparin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Heparin by Country
9.1.1 Latin America Heparin Sales by Country
9.1.2 Latin America Heparin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Heparin Market Facts & Figures by Type
9.3 Central & South America Heparin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Heparin by Country
10.1.1 Middle East and Africa Heparin Sales by Country
10.1.2 Middle East and Africa Heparin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Heparin Market Facts & Figures by Type
10.3 Middle East and Africa Heparin Market Facts & Figures by Application
11 Company Profiles
11.1 Hepalink
11.1.1 Hepalink Corporation Information
11.1.2 Hepalink Description, Business Overview and Total Revenue
11.1.3 Hepalink Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hepalink Heparin Products Offered
11.1.5 Hepalink Recent Development
11.2 Changshan Pharm
11.2.1 Changshan Pharm Corporation Information
11.2.2 Changshan Pharm Description, Business Overview and Total Revenue
11.2.3 Changshan Pharm Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Changshan Pharm Heparin Products Offered
11.2.5 Changshan Pharm Recent Development
11.3 Qianhong Bio-pharma
11.3.1 Qianhong Bio-pharma Corporation Information
11.3.2 Qianhong Bio-pharma Description, Business Overview and Total Revenue
11.3.3 Qianhong Bio-pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Qianhong Bio-pharma Heparin Products Offered
11.3.5 Qianhong Bio-pharma Recent Development
11.4 Opocrin
11.4.1 Opocrin Corporation Information
11.4.2 Opocrin Description, Business Overview and Total Revenue
11.4.3 Opocrin Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Opocrin Heparin Products Offered
11.4.5 Opocrin Recent Development
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description, Business Overview and Total Revenue
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Heparin Products Offered
11.5.5 Pfizer Recent Development
11.6 Aspen Oss
11.6.1 Aspen Oss Corporation Information
11.6.2 Aspen Oss Description, Business Overview and Total Revenue
11.6.3 Aspen Oss Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Aspen Oss Heparin Products Offered
11.6.5 Aspen Oss Recent Development
11.7 King-friend Biochemical Pharmaceutical
11.7.1 King-friend Biochemical Pharmaceutical Corporation Information
11.7.2 King-friend Biochemical Pharmaceutical Description, Business Overview and Total Revenue
11.7.3 King-friend Biochemical Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 King-friend Biochemical Pharmaceutical Heparin Products Offered
11.7.5 King-friend Biochemical Pharmaceutical Recent Development
11.8 Bioibérica
11.8.1 Bioibérica Corporation Information
11.8.2 Bioibérica Description, Business Overview and Total Revenue
11.8.3 Bioibérica Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bioibérica Heparin Products Offered
11.8.5 Bioibérica Recent Development
11.9 Dongcheng Biochemicals
11.9.1 Dongcheng Biochemicals Corporation Information
11.9.2 Dongcheng Biochemicals Description, Business Overview and Total Revenue
11.9.3 Dongcheng Biochemicals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Dongcheng Biochemicals Heparin Products Offered
11.9.5 Dongcheng Biochemicals Recent Development
11.10 Jiulong Biochemicals
11.10.1 Jiulong Biochemicals Corporation Information
11.10.2 Jiulong Biochemicals Description, Business Overview and Total Revenue
11.10.3 Jiulong Biochemicals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Jiulong Biochemicals Heparin Products Offered
11.10.5 Jiulong Biochemicals Recent Development
11.1 Hepalink
11.1.1 Hepalink Corporation Information
11.1.2 Hepalink Description, Business Overview and Total Revenue
11.1.3 Hepalink Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hepalink Heparin Products Offered
11.1.5 Hepalink Recent Development
11.12 Xinbai
11.12.1 Xinbai Corporation Information
11.12.2 Xinbai Description, Business Overview and Total Revenue
11.12.3 Xinbai Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Xinbai Products Offered
11.12.5 Xinbai Recent Development
11.13 Yino Pharma
11.13.1 Yino Pharma Corporation Information
11.13.2 Yino Pharma Description, Business Overview and Total Revenue
11.13.3 Yino Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Yino Pharma Products Offered
11.13.5 Yino Pharma Recent Development
11.14 Deebio
11.14.1 Deebio Corporation Information
11.14.2 Deebio Description, Business Overview and Total Revenue
11.14.3 Deebio Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Deebio Products Offered
11.14.5 Deebio Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Heparin Market Estimates and Projections by Region
12.1.1 Global Heparin Sales Forecast by Regions 2021-2026
12.1.2 Global Heparin Revenue Forecast by Regions 2021-2026
12.2 North America Heparin Market Size Forecast (2021-2026)
12.2.1 North America: Heparin Sales Forecast (2021-2026)
12.2.2 North America: Heparin Revenue Forecast (2021-2026)
12.2.3 North America: Heparin Market Size Forecast by Country (2021-2026)
12.3 Europe Heparin Market Size Forecast (2021-2026)
12.3.1 Europe: Heparin Sales Forecast (2021-2026)
12.3.2 Europe: Heparin Revenue Forecast (2021-2026)
12.3.3 Europe: Heparin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Heparin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Heparin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Heparin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Heparin Market Size Forecast by Region (2021-2026)
12.5 Latin America Heparin Market Size Forecast (2021-2026)
12.5.1 Latin America: Heparin Sales Forecast (2021-2026)
12.5.2 Latin America: Heparin Revenue Forecast (2021-2026)
12.5.3 Latin America: Heparin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Heparin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Heparin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Heparin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Heparin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Heparin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Heparin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Heparin Market Segments
Table 2. Ranking of Global Top Heparin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Heparin Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Heparin Sodium
Table 5. Major Manufacturers of Heparin Calcium
Table 6. Major Manufacturers of Other
Table 7. COVID-19 Impact Global Market: (Four Heparin Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Heparin Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Heparin Players to Combat Covid-19 Impact
Table 12. Global Heparin Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Heparin Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Heparin Sales by Regions 2015-2020 (K MT)
Table 15. Global Heparin Sales Market Share by Regions (2015-2020)
Table 16. Global Heparin Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Heparin Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Heparin Sales Share by Manufacturers (2015-2020)
Table 19. Global Heparin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin as of 2019)
Table 21. Heparin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Heparin Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Heparin Price (2015-2020) (USD/MT)
Table 24. Heparin Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Heparin Product Type
Table 26. Date of International Manufacturers Enter into Heparin Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Heparin Sales by Type (2015-2020) (K MT)
Table 29. Global Heparin Sales Share by Type (2015-2020)
Table 30. Global Heparin Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Heparin Revenue Share by Type (2015-2020)
Table 32. Heparin Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Heparin Sales by Application (2015-2020) (K MT)
Table 34. Global Heparin Sales Share by Application (2015-2020)
Table 35. North America Heparin Sales by Country (2015-2020) (K MT)
Table 36. North America Heparin Sales Market Share by Country (2015-2020)
Table 37. North America Heparin Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Heparin Revenue Market Share by Country (2015-2020)
Table 39. North America Heparin Sales by Type (2015-2020) (K MT)
Table 40. North America Heparin Sales Market Share by Type (2015-2020)
Table 41. North America Heparin Sales by Application (2015-2020) (K MT)
Table 42. North America Heparin Sales Market Share by Application (2015-2020)
Table 43. Europe Heparin Sales by Country (2015-2020) (K MT)
Table 44. Europe Heparin Sales Market Share by Country (2015-2020)
Table 45. Europe Heparin Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Heparin Revenue Market Share by Country (2015-2020)
Table 47. Europe Heparin Sales by Type (2015-2020) (K MT)
Table 48. Europe Heparin Sales Market Share by Type (2015-2020)
Table 49. Europe Heparin Sales by Application (2015-2020) (K MT)
Table 50. Europe Heparin Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Heparin Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Heparin Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Heparin Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Heparin Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Heparin Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Heparin Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Heparin Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Heparin Sales Market Share by Application (2015-2020)
Table 59. Latin America Heparin Sales by Country (2015-2020) (K MT)
Table 60. Latin America Heparin Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Heparin Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Heparin Revenue Market Share by Country (2015-2020)
Table 63. Latin America Heparin Sales by Type (2015-2020) (K MT)
Table 64. Latin America Heparin Sales Market Share by Type (2015-2020)
Table 65. Latin America Heparin Sales by Application (2015-2020) (K MT)
Table 66. Latin America Heparin Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Heparin Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Heparin Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Heparin Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Heparin Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Heparin Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Heparin Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Heparin Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Heparin Sales Market Share by Application (2015-2020)
Table 75. Hepalink Corporation Information
Table 76. Hepalink Description and Major Businesses
Table 77. Hepalink Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Hepalink Product
Table 79. Hepalink Recent Development
Table 80. Changshan Pharm Corporation Information
Table 81. Changshan Pharm Description and Major Businesses
Table 82. Changshan Pharm Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Changshan Pharm Product
Table 84. Changshan Pharm Recent Development
Table 85. Qianhong Bio-pharma Corporation Information
Table 86. Qianhong Bio-pharma Description and Major Businesses
Table 87. Qianhong Bio-pharma Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Qianhong Bio-pharma Product
Table 89. Qianhong Bio-pharma Recent Development
Table 90. Opocrin Corporation Information
Table 91. Opocrin Description and Major Businesses
Table 92. Opocrin Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Opocrin Product
Table 94. Opocrin Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Major Businesses
Table 97. Pfizer Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. Aspen Oss Corporation Information
Table 101. Aspen Oss Description and Major Businesses
Table 102. Aspen Oss Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Aspen Oss Product
Table 104. Aspen Oss Recent Development
Table 105. King-friend Biochemical Pharmaceutical Corporation Information
Table 106. King-friend Biochemical Pharmaceutical Description and Major Businesses
Table 107. King-friend Biochemical Pharmaceutical Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. King-friend Biochemical Pharmaceutical Product
Table 109. King-friend Biochemical Pharmaceutical Recent Development
Table 110. Bioibérica Corporation Information
Table 111. Bioibérica Description and Major Businesses
Table 112. Bioibérica Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Bioibérica Product
Table 114. Bioibérica Recent Development
Table 115. Dongcheng Biochemicals Corporation Information
Table 116. Dongcheng Biochemicals Description and Major Businesses
Table 117. Dongcheng Biochemicals Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Dongcheng Biochemicals Product
Table 119. Dongcheng Biochemicals Recent Development
Table 120. Jiulong Biochemicals Corporation Information
Table 121. Jiulong Biochemicals Description and Major Businesses
Table 122. Jiulong Biochemicals Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Jiulong Biochemicals Product
Table 124. Jiulong Biochemicals Recent Development
Table 125. Tiandong Corporation Information
Table 126. Tiandong Description and Major Businesses
Table 127. Tiandong Heparin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Tiandong Product
Table 129. Tiandong Recent Development
Table 130. Xinbai Corporation Information
Table 131. Xinbai Description and Major Businesses
Table 132. Xinbai Heparin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Xinbai Product
Table 134. Xinbai Recent Development
Table 135. Yino Pharma Corporation Information
Table 136. Yino Pharma Description and Major Businesses
Table 137. Yino Pharma Heparin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Yino Pharma Product
Table 139. Yino Pharma Recent Development
Table 140. Deebio Corporation Information
Table 141. Deebio Description and Major Businesses
Table 142. Deebio Heparin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Deebio Product
Table 144. Deebio Recent Development
Table 145. Global Heparin Sales Forecast by Regions (2021-2026) (K MT)
Table 146. Global Heparin Sales Market Share Forecast by Regions (2021-2026)
Table 147. Global Heparin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 148. Global Heparin Revenue Market Share Forecast by Regions (2021-2026)
Table 149. North America: Heparin Sales Forecast by Country (2021-2026) (K MT)
Table 150. North America: Heparin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Europe: Heparin Sales Forecast by Country (2021-2026) (K MT)
Table 152. Europe: Heparin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Asia Pacific: Heparin Sales Forecast by Region (2021-2026) (K MT)
Table 154. Asia Pacific: Heparin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 155. Latin America: Heparin Sales Forecast by Country (2021-2026) (K MT)
Table 156. Latin America: Heparin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Middle East and Africa: Heparin Sales Forecast by Country (2021-2026) (K MT)
Table 158. Middle East and Africa: Heparin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 160. Key Challenges
Table 161. Market Risks
Table 162. Main Points Interviewed from Key Heparin Players
Table 163. Heparin Customers List
Table 164. Heparin Distributors List
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Sales Market Share by Type in 2020 & 2026
Figure 3. Heparin Sodium Product Picture
Figure 4. Heparin Calcium Product Picture
Figure 5. Other Product Picture
Figure 6. Global Heparin Sales Market Share by Application in 2020 & 2026
Figure 7. UFH
Figure 8. LMWH
Figure 9. Heparin Report Years Considered
Figure 10. Global Heparin Market Size 2015-2026 (US$ Million)
Figure 11. Global Heparin Sales 2015-2026 (K MT)
Figure 12. Global Heparin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Heparin Sales Market Share by Region (2015-2020)
Figure 14. Global Heparin Sales Market Share by Region in 2019
Figure 15. Global Heparin Revenue Market Share by Region (2015-2020)
Figure 16. Global Heparin Revenue Market Share by Region in 2019
Figure 17. Global Heparin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Heparin Revenue in 2019
Figure 19. Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Heparin Sales Market Share by Type (2015-2020)
Figure 21. Global Heparin Sales Market Share by Type in 2019
Figure 22. Global Heparin Revenue Market Share by Type (2015-2020)
Figure 23. Global Heparin Revenue Market Share by Type in 2019
Figure 24. Global Heparin Market Share by Price Range (2015-2020)
Figure 25. Global Heparin Sales Market Share by Application (2015-2020)
Figure 26. Global Heparin Sales Market Share by Application in 2019
Figure 27. Global Heparin Revenue Market Share by Application (2015-2020)
Figure 28. Global Heparin Revenue Market Share by Application in 2019
Figure 29. North America Heparin Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Heparin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Heparin Sales Market Share by Country in 2019
Figure 32. North America Heparin Revenue Market Share by Country in 2019
Figure 33. U.S. Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Heparin Market Share by Type in 2019
Figure 38. North America Heparin Market Share by Application in 2019
Figure 39. Europe Heparin Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Heparin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Heparin Sales Market Share by Country in 2019
Figure 42. Europe Heparin Revenue Market Share by Country in 2019
Figure 43. Germany Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Heparin Market Share by Type in 2019
Figure 54. Europe Heparin Market Share by Application in 2019
Figure 55. Asia Pacific Heparin Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Heparin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Heparin Sales Market Share by Region in 2019
Figure 58. Asia Pacific Heparin Revenue Market Share by Region in 2019
Figure 59. China Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Heparin Market Share by Type in 2019
Figure 82. Asia Pacific Heparin Market Share by Application in 2019
Figure 83. Latin America Heparin Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Heparin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Heparin Sales Market Share by Country in 2019
Figure 86. Latin America Heparin Revenue Market Share by Country in 2019
Figure 87. Mexico Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Heparin Market Share by Type in 2019
Figure 94. Latin America Heparin Market Share by Application in 2019
Figure 95. Middle East and Africa Heparin Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Heparin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Heparin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Heparin Revenue Market Share by Country in 2019
Figure 99. Turkey Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 104. UAE Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Heparin Market Share by Type in 2019
Figure 106. Middle East and Africa Heparin Market Share by Application in 2019
Figure 107. Hepalink Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Changshan Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Qianhong Bio-pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Opocrin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Aspen Oss Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. King-friend Biochemical Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Bioibérica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Dongcheng Biochemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Jiulong Biochemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Tiandong Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Xinbai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Yino Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Deebio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Heparin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. North America Heparin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Heparin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Europe Heparin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Heparin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Asia Pacific Heparin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Heparin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Latin America Heparin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Heparin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 130. Middle East and Africa Heparin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs